OSLO, Norway, Sept. 30, 2021 /PRNewswire/ -- Targovax
ASA (OSE: TRVX) announces the appointment of
Ola Melin as Head of Manufacturing.
He will take a leading role in driving Targovax's Chemistry,
Manufacturing, and Controls (CMC) program forward. Ola will be a
member of Targovax's management team.
Ola Melin joins Targovax with
over 25 years' experience in Biologics development, manufacturing,
and supply, most recently as Director of Technical Operations at
OxThera AB, where he was responsible for clinical supply and for
establishing a commercially ready manufacturing process and supply
chain. Prior to that Ola spent eighteen years at Biovitrum and Sobi
AB, where he held senior leadership roles as Head of External
Manufacturing and Head of Product Supply, as well as other CMC
positions. Ola started his career with manufacturing process
development at Pharmacia. Ola has studied Biochemical engineering
at Mälardalen University.
Øystein Soug, CEO, commented, "It is with great
enthusiasm we welcome Ola Melin to
Targovax! With his broad experience with supply chain, clinical and
commercial manufacturing, and his previous experience in launching
products, he will bring important and valuable knowledge to
Targovax. His CMC experience within the field of biologics
development and manufacturing will contribute significantly to the
execution of Targovax's strategic plan."
Ola Melin added, "I am
excited to join Targovax and be a part of the next development
steps for its's lead clinical candidate ONCOS-102. The
class-leading data in CPI refractory advanced melanoma, together
with powerful immune activation, makes this an exciting product
candidate and I look forward to contributing to the further
development of this promising novel immune activator therapy that
could make a huge difference to those diagnosed with cancer."
Ola Melin will commence as Head
of Manufacturing on 1st October.
For further information, please contact:
Oystein Soug, CEO
Phone: +47 906 56 525
Renate Birkeli, Investor
Phone: +47 922 61 624
Andreas Tinglum - Corporate
Phone: +47 9300 1773
This information was brought to you by Cision